Search Results - Kenneth Schikler
- Showing 1 - 3 results of 3
-
1
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial by Navita L. Mallalieu, Sunethra Wimalasundera, Joy C. Hsu, Wendy Douglass, Chris Wells, Inmaculada Calvo Penades, Ruben Cuttica, Hans-Iko Huppertz, Rik Joos, Yukiko Kimura, Diana Milojevic, Margalit Rosenkranz, Kenneth Schikler, Tamas Constantin, Carine Wouters
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Correction: Stoll et al. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. <i>Children</i> 2022, <i>9</i>, 569 by Matthew L. Stoll, Kimberly DeQuattro, Zhixiu Li, Henna Sawhney, Pamela F. Weiss, Peter A. Nigrovic, Tracey B. Wright, Kenneth Schikler, Barbara Edelheit, Casey D. Morrow, John D. Reveille, Matthew A. Brown, Lianne S. Gensler
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients by Matthew L. Stoll, Kimberly DeQuattro, Zhixiu Li, Henna Sawhney, Pamela F. Weiss, Peter A. Nigrovic, Tracey B. Wright, Kenneth Schikler, Barbara Edelheit, Casey D. Morrow, John D. Reveille, Matthew A. Brown, Lianne S. Gensler
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book